Headache and medication overuse: Are clinical case series appropriate to reveal differential risks of different medications?

Expert Opinion on Drug Safety

Volumn 9, Issue 3, 2010, Pages 397-406

  Haag, Gunther ^a  

^a Michael Balint Klinik   (Germany)

Author keywords

Clinical case series; Differential risk of MOH; Medication overuse headache; Selection bias

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BUTALBITAL; CAFFEINE; CODEINE; ERGOTAMINE DERIVATIVE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROCHLORPERAZINE; PROPYPHENAZONE; TRIPTAN DERIVATIVE;

DRUG INDUCED HEADACHE; HEADACHE; HUMAN; MIGRAINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

ANALGESICS; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; HEADACHE; HEADACHE DISORDERS, SECONDARY; HUMANS; RISK FACTORS; SEROTONIN RECEPTOR AGONISTS; TRYPTAMINES;

EID: 77951634108     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740331003598857     Document Type: Review

References (46)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition (ICHD-2). Cephalalgia 2004;24:S9-160
2. Giammarco R Edmeads J Dodick D. Critical decisions in headache management. Decker Hamilton; 1998
3. Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;9:193-210
4. Dodick DW, Silberstein SD. How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia 2008;28:1209-1217
5. Jensen R, Bendtsen L. Medication overuse headache in Scandinavia. Cephalalgia 2008;28:1237-1239
6. Evers S, Suhr B, Bauer B, et al. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol 1999;246:802-809
7. Jelinski SE, Becker WJ, Christie SN, et al. Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada. Cephalalgia 2006;26:578-588
8. Relja G, Granato A, Antonello RM, et al. Headache induced by chronic substance use: an analysis of medication overused and required minimum dose. Headache 2004;44:148-153
9. Zeeberg P, Olesen J, Jensen R Probable medication-overuse headache: the effect of a 2-month drugfree period. Neurology 2006;66:1894-1898
10. Imai N, Kitamura E, Konishi T, et al. Clinical features of probable medication-overuse headache: a retrospective study in Japan. Cephalalgia 2007;27:1020-1023
11. Ellenberg JH. Cohort studies. Selection bias in observational and experimental studies. Stat Med 1994;13:557-567
12. Bøe MG, Mygland A, Salvesen R Prednisolone does not reduce withdrawal headache-A radomized, double-blind study. Neurology 2007;69:26-31
13. Ravishankar K. Medication overuse headache in India. Cephalalgia 2008;28:1223-1226
14. Fuh J-L, Wang S-J, Lu S-R, et al. Does medication overuse headache represent a behavior of dependence? Pain 2005;119:49-55
15. Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, et al. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 2007;27:1219-1225
16. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002;359:248-252
17. Meskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006;46:766-772
18. Maillard M, Burnier M. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 2006;5:83-94
19. Graham DJ. COX-2 inhibitors, other NSAIDs, and cardiovascular risk-the seduction of common sense. JAMA 2006;296:1653-1656
20. Ferrari A, Coccia C, Sternieri E. Past, present, and future prospects of medication-overuse headache classification. Headache 2008;48:1096-1102
21. Driscoll P, Lecky F, Crosby M. An introduction to everyday statistics-part 1. Emerg Med J 2000;17:205-211
22. Waters WE. The pontyridd headache survey. Headache 1974;14:81-90
23. Nikiforow R, Hokkanen E. An epidemiological study of headache in an urban and a rural population in northern Finland. Headache 1978;18:137-145
24. Colás R, Muñoz P, Temprano R, et al. Chronic daily headache with analgesic overuse Epidemiology and impact on quality of life. Neurology 2004;62:1338-1342
25. Straube A, Pfaffenrath V, Ladwig K-H, et al. Prevalence of chronic migraine and medication overuse headache in Germany-the German DMKG headache study. Cephalalgia 2009, doi:10.1111/j.1468-2982.2009.01906.x
26. Bøe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia 2009,29:855-863
27. Sances G, Ghiotto N, Galli F, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia 2009, doi:10.1111/j.1468-2982.2009.01934.x
28. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008,48:1157-1168
29. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2005;65:180
30. Bekkelund SI, Salvesen R. Drug-associated headache is unrecognised in patients treated at a neurological centre. Acta Neurol Scand 2002;105:120-123
31. Scher AI, Stewart WF, Liberman J, et al. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506
32. Castillo J, Munoz P, Guitera V, et al. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-196
33. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000;54:314-319
34. Lu SR, Fuh JL, Chen WT, et al. Chronic daily headache in Taipei, Taiwan: prevalence, follow up and outcome predictors. Cephalalgia 2001;21:980-986
35. Lanteri-Minet M, Auray JP, El Hasnaoui A, et al. Prevalence and description of chronic daily headache in the general population in France. Pain 2003;102:143-149
36. Zwart JA, Dyb G, Hagen K, et al. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003;61:160-164
37. Aaseth K, Grande RB, Kværner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia 2008;28:705-713 (Pubitemid 351799748)
38. Headache Classification Committee. Olesen J, Bousser M-G, Diener H-C, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26:742-746
39. Maizels M, Burchette R. Rapid and sensitive paradigm for screening patients with headache in primary care settings. Headache 2003;43:441-450
40. Ward TN. Medication overuse headache. Prim Care Clin Office Pract 2004;31:369-380
41. Allena M, Katsarava Z, Nappi G, the COMOESTAS Consortium. From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain 2009;10:71-76
42. Diener H-C, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004;3:475-483
43. Rychetnik L, Hawe P, Waters E, et al. A glossary for evidence based public health. J Epidemiol Community Health 2004;58:538-545
44. Bigal ME, Lipton RB. Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep 2009;13:301-307
45. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300
46. Haag G, Diener HC, May A, et al. Selbstmedikation bei Migräne und Kopfschmerz vom Spannungstyp-Evidenzbasierte Empfehlungen der Deutschen Migräne-und Kopfschmerzgesellschaft (DMKG), der Deutschen Gesellschaft für Neurologie ̈ (DGN), der Osterreichischen ̈ Kopfschmerzgesellschaft (OKSG) und der Schweizerischen Kopfwehgesellschaft (SKG). Self medication in migraine and tension type headache-evidence-based guidelines of the German, Austrian andSwiss headache societies and the German Society of Neurology. ervenheilkunde 2009;28:382-397